Get the Stockscreener App
0.65
3.19%
+0.0201
After Hours:
.6599
0.0099
+1.52%
Clover Health Investments Corp stock is currently priced at $0.65, with a 24-hour trading volume of 3.99M.
It has seen a +3.19% increased in the last 24 hours and a -20.85% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $0.6268 pivot point. If it approaches the $0.6559 resistance level, significant changes may occur.
Previous Close:
$0.6299
Open:
$0.6275
24h Volume:
3.99M
Market Cap:
$321.94M
Revenue:
$2.03B
Net Income/Loss:
$-213.36M
P/E Ratio:
-1.1907
EPS:
-0.5459
Net Cash Flow:
$-116.46M
1W Performance:
+4.55%
1M Performance:
-20.85%
6M Performance:
-29.96%
1Y Performance:
-15.60%
1D Range:
$0.623
$0.6652
52W Range:
$0.606
$1.63
Clover Health Investments Corp Stock (CLOV) Company Profile
Name
Clover Health Investments Corp
Sector
Industry
Phone
201-821-8758
Address
Harborside Financial Center, Plaza 10 3 Second Street Suite 803, Jersey City
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Feb-02-22 | Upgrade | Cowen | Underperform → Market Perform |
| Jan-19-22 | Initiated | SVB Leerink | Mkt Perform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Jan-07-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-10-21 | Initiated | Cowen | Underperform |
| Sep-02-21 | Resumed | Citigroup | Neutral |
| Jul-12-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| May-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Feb-02-21 | Initiated | Citigroup | Buy |
| Feb-01-21 | Initiated | JP Morgan | Neutral |
View All
Clover Health Investments Corp Stock (CLOV) Latest News
Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024
GlobeNewswire Inc.
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
GlobeNewswire Inc.
Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions
GlobeNewswire Inc.
Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Benzinga
Clover Health Investments Corp Stock (CLOV) Financials Data
Clover Health Investments Corp (CLOV) Revenue 2024
CLOV reported a revenue (TTM) of $2.03 billion for the quarter ending December 31, 2023, a -41.50% decline year-over-year.
Clover Health Investments Corp (CLOV) Net Income 2024
CLOV net income (TTM) was -$213.36 million for the quarter ending December 31, 2023, a +37.17% increase year-over-year.
Clover Health Investments Corp (CLOV) Cash Flow 2024
CLOV recorded a free cash flow (TTM) of -$116.45 million for the quarter ending December 31, 2023, a +59.96% increase year-over-year.
Clover Health Investments Corp (CLOV) Earnings per Share 2024
CLOV earnings per share (TTM) was -$0.44 for the quarter ending December 31, 2023, a +38.54% growth year-over-year.
Clover Health Investments Corp Stock (CLOV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Loengard Anna U | Director |
Mar 14 '24 |
Buy |
0.73 |
13,625 |
9,946 |
15,125 |
| Loengard Anna U | Director |
Sep 06 '23 |
Buy |
1.30 |
11,000 |
14,300 |
10,000 |
About Clover Health Investments Corp
Clover Health Investments, Corp. operates as a healthcare insurance provider. The company was incorporated in 2014 and is based in Jersey City, New Jersey. Clover Health Investments, Corp. operates as a subsidiary of Nj Healthcare Investments, LLC.
0.00%
3.66%
Cap:
|
Volume (24h):